Connect with us
WEDNESDAY, Dec. 2, 2020 (HealthDay News) -- Cancer survivors have higher odds of dying from seasonal flu, suggesting they may also be at increased risk from...
A team of nanoengineers has developed new and improved probes, known as positive controls, that could make it easier to validate rapid, point-of-care diagnostic...
Pediatricians and other health experts called for children to be enrolled in vaccine trials earlier and now worry that the window for immunizing kids before the...
A team of researchers at the University of Hong Kong has identified a panel of SARS-CoV-2 variants, called Del-mut, which contains a deletion in the S1/S2...
TARGIT-IORT long-term data demonstrates equivalent outcomes to traditional 3- to 6-week radiotherapy, significantly reducing COVID-19 risk to patients amidst coming...
QurAlis announces two poster presentations on preclinical precision medicine ALS programs at the 31st International Symposium on ALS/MND.
/PRNewswire/ -- Cork software technology firm Digisoft and international leisure and attractions technology provider accesso Technology Group plc (AIM: ACSO)...
They face violence and aggression on wards and in the community, health chiefs say.
A new diagnostic agent, Gallium 68 PSMA-11, has been approved for institutional use in the PET imaging of PSMA-positive lesions in men with prostate cancer.
The U.K.’s regulator had been delegated much of the work to authorize Europe’s medicines, and seemed better prepared than most to approve the vaccine